ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · IEX Real-Time Price · USD
5.14
-0.25 (-4.64%)
At close: Jul 19, 2024, 4:30 PM
5.21
+0.07 (1.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
ESSA Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ESSA Pharma stock have an average target of 17, which predicts an increase of 230.74% from the current stock price of 5.14.
Analyst Consensus: Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for ESSA Pharma stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $17 | Buy | Maintains | $17 | +230.74% | May 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +230.74% | Dec 13, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 | Buy | Reiterates | $17 | +230.74% | Aug 9, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +230.74% | Jun 26, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $50 → $20 | Buy | Maintains | $50 → $20 | +289.11% | May 12, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.84
from -0.60
EPS Next Year
-1.04
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 23.4M | 183.1M | 357.7M |
| Avg | n/a | n/a | 5.7M | 44.5M | 109.9M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 3,123.9% | 704.4% |
| Avg | - | - | - | 682.9% | 147.1% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.78 | -0.65 | -0.70 | -0.33 | 1.63 |
| Avg | -0.84 | -1.04 | -1.39 | -1.59 | -0.91 |
| Low | -0.95 | -2.06 | -2.77 | -3.68 | -2.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.